NTRR completes research and development of new erectile dysfunction treatment

With Neutra Corp.'s (OTCBB: NTRR) Pure Plus weight-loss supplement already in the midst of clinical trials, the company announced today that it has completed research and development of its next product in the Pure Plus line: an all-natural erectile dysfunction (ED) treatment.

The new supplement will boost male testosterone levels, increase circulation and support an increased libido, helping men to reclaim their sexual potency without the high cost and side effects of prescription drugs.

Like the other supplements planned for NTRR's Pure Plus brand, the new supplement will be infused with a unique Bio-energy boost. The infusion will modify the supplement's ingredients on the subatomic level, enhancing their properties and increasing their power.

NTRR's new ED formula could soon be the first all-natural product on the market that harnesses the science of Bio-Energy to help turbocharge sexual function. The company expects this simple, effective innovation to differentiate Pure Plus from competitors and fuel rapid company growth in the multi-billion-dollar global nutraceuticals industry.

Neutra Corp. is developing new products to compete in the rising nutraceuticals industry alongside Qualsec Vitamin Spice  (OTC: VTMS.PK), Nutraceutical International Corp. (NASDAQ: NUTR), Express Scripts, Inc. (NASDAQ: ESRX), and Vitamin Shoppe (NYSE: VSI).